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INTRODUCTION
Influenza is the most common and widespread infectious 
disease on the globe. Thus, according to estimates, influenza 
and acute respiratory diseases (ARD) annually affects from 4 
to 15% of the world’s population, and 250-450 thousand peo-
ple die from influenza and its complications [1]. Incidence of 
disease increases to 50-70% during the influenza pandemics, 
which are associated with genetic shift in the pathogen in the 
human population. Moreover, mortality from influenza and its 
complications ranks first among all infectious diseases [2, 3, 4, 5]
Pneumonia remains the main cause of morbidity, hos-
pitalization and mortality in an influenza, and therefore it 
is a very complicated health problem worldwide, includ-
ing developed countries. It is known that the influenza is 
complicated with pneumonia in 10-20% of all patients with 
influenza, and in about half of the hospitalized patients [6, 
7]. According to present knowledge, there is a tendency for 
a severe course of community-acquired pneumonia (CAP) 
that occurs with influenza [2]. Often such pneumonia is 
characterized by severe intoxication syndrome, hemody-
namic disorders, severe respiratory failure with the devel-
opment of acute respiratory distress syndrome (ARDS).
In recent years, reports in the scientific literature indicate 
that the etiology of pneumonia has expanded significantly, 
and among the agents that can cause severe pneumonia, 
there may be various associations of influenza virus with 
bacteria [4]. 
At the same time, only some reports describe the de-
pendence of the severity of pneumonia on the etiological 
factor and attempt to distinguish the characteristic clinical 
features of pneumonia caused by a particular pathogen or 
a combination thereof. 
Thus, the problem of influenza-associated pneumonia 
is topical, which makes the need for further study of the 
features of their clinical course, generalization of the results 
of laboratory and instrumental and radiological studies 
to optimize diagnostic and therapeutic tactics taking into 
account the etiological structure.
THE AIM 
To analyze the epidemiological data and clinical course of 
pneumonia as a complication of influenza in the Poltava 
region, depending on the etiological factor. 
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ABSTRACT
The aim: To analyze the epidemiological data and clinical course of pneumonia as a complication of influenza in the Poltava region, depending on the etiological agent. 
Materials and methods: We have analysed the data of the official reporting documentation provided by the State Institution “Poltava Regional Laboratory Center of the 
Ministry of Health of Ukraine” and the chart of patients with a laboratory confirmed diagnosis of influenza who were in inpatient treatment at the Poltava Regional Clinical 
Infectious Hospital (PRCIH) in 2016-2018 years. In more detail, we examined 95 patients with pneumonia, which complicated the course of the flu. There were 43 (45.26%) 
female patients, − 52 (54.74%) male patients, aged 18 to 80 years.
Results: Studies have shown that despite a decrease in the incidence of influenza in recent years, the incidence of pneumonia, which complicated the course of the flu, remained 
consistently high (19.7% – 20.8%) with bacteriological isolation of S.pneumoniae (22.11%), S.aureus (13.68%), Haemophilus influenza (4.21%) and E.coli (3.16%). Severe course 
of pneumonia with bloody sputum, evident shortness of breath, bilateral lung damage, and need for oxygen support were significantly more frequently reported in patients 
with isolated S.pneumoniae and S.aureus. However, the severe course of the disease with the formation of abscesses in the lungs was observed only in the group S.aureus despite 
the relatively young age of such patients and significantly fewer risk factors for severe influenza and comorbidities.
Conclusions: The study showed a consistently high incidence of pneumonia, which complicated the flu and caused by S.pneumoniae, S.aureus, Haemophilus influenza and 
E.coli. Pneumonia caused by S.pneumoniae and S.aureus, were characterized the most severe course; however, a severe course with the formation of abscesses in the lung tissue 
was observed only in the group of S.aureus.
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MATERIALS AND METHODS 
To achieve this aim we have analysed the data of the 
official reporting documentation provided by the State 
Institution “Poltava Regional Laboratory Center of the 
Ministry of Health of Ukraine” and the chart of patients 
with a laboratory confirmed diagnosis of influenza who 
were in inpatient treatment at the Poltava Regional Clinical 
Infectious Hospital (PRCIH) in 2016-2018. In more detail, 
we examined 95 patients with pneumonia, which compli-
cated the course of the flu. There were 43 (45.26%) female 
patients, − 52 (54.74%) male patients, aged 18 to 80 years. 
Influenza was diagnosed based on epidemiological, 
clinical data, serological findings with the determination of 
the increasing of specific antibody titers in the hemaggluti-
nation inhibition reaction with influenza diagnostic agent 
A/H1N1, A/H2N2, A/H3N2, B and the detection of Influ-
enza virus A/H1N1, A/H2N2, A/H3N2, B in polymerase 
chain reaction (PCR). Among the factors that complicated 
the course of the disease, we considered obesity, chronic 
pathology of the cardiovascular and respiratory systems, 
diabetes mellitus, immunodeficiency of various etiology 
and neoplasms. 
The diagnosis of pneumonia was established on the basis 
of a comprehensive analysis of epidemiological and clinical 
and laboratory data with mandatory X-ray/tomographic 
confirmation. The course of pneumonia and the need for 
hospitalization to the intensive care unit was determined on 
the IDSA/ATS (American Thoracic Society and Infectious 
Diseases Society of America), wherein we were guided by 
the order of the Ministry of Health of Ukraine from March 
19, 2007 No. 128, and classified the patients into one of 
five groups, depending on the severity and the presence 
of concomitant pathology. Treatment of patients with 
pneumonia I-III group was performed in the diagnostic 
department of PRCIH; IV − in the intensive care unit. All 
patients received antiviral therapy (oseltamivir 150 mg/day 
in the case of pneumonia of II-III group, and 300 mg/day 
in the case of pneumonia of IV group), antibiotic therapy 
in accordance with the Protocol of treatment orders of the 
Ministry of Health of Ukraine from May 20, 2009, No. 189, 
and from November 18, 2009, No. 832), oxygen therapy 
for indications. 
We have conducted a comprehensive examination of all 
patients with determination of pulse oxygen saturation 
(SpO2), bacteriological examination of sputum, labora-
tory and additional tests depending on concomitant and 
diagnosed pathology with the involvement of consultants 
of the corresponding profile. 
For statistical processing of the research results were 
used parametric and non-parametric methods of varia-
tional statistics. The difference was considered statistically 
significant at p < 0.05. 
RESULTS AND DISCUSSION 
The conducted studies showed that 1344 cases of influenza 
were registered in 2016 according to the official reporting 
documentation provided by the State Institution “Poltava 
Regional Laboratory Center of the Ministry of Health of 
Ukraine”, in Poltava Region, which amounted to 93.91 cases 
per 100 thousand population, and 305892 cases of acute 
infections of the upper respiratory tract with multiple or in-
determinate localization (21374.46 cases per 100 thousand 
population). In 2017, the influenza has been diagnosed 
in 216 patients in the Poltava region (15.22 cases per 100 
thousand population), and acute infections of the upper 
respiratory tract with multiple or uncertain localizations 
have been diagnosed in 232050 patients (16353.32 cases 
per 100 thousand population). In 2018, the diagnosis 
of “Influenza” was established in 359 patients of Poltava 
region (25.53 cases per 100 thousand population), and 
the diagnosis of acute infections of the upper respiratory 
tract with multiple or uncertain localizations – in 224905 
patients (15996,19 cases per 100 thousand population). We 
also observed a similar tendency to reduce the incidence 
of influenza in recent years according to the data of PR-
CIH, as indirectly indicated by the number of hospitalized 
patients with this pathology. Thus, in 2016, 499 patients 
were treated in PRCIH with the diagnosis of “Influenza” 
(65 of them had influenza A, 2 had influenza B, and 432 
were diagnosed with influenza clinically with clear clinical 
and epidemiological data), then in 2017, there were only 
104 patients with influenza (influenza A – in 25 patients, 
influenza B – in 3 patients, influenza (clinically) – in 76 
patients), and in 2018 – 187 patients (influenza A – 32, 
influenza B – 27, influenza (clinically) – 128). It should 
be noted that the incidence rate has not shown significant 
growth in recent years, but the frequency of pneumonia, 
which complicated the influenza according to the PRCIH 
data, remained at a stable high level (20.84% in 2016, 
20.19% in 2017 and 19.7% in 2018). 
Among patients with pneumonia, in a microbiological 
examination of sputum a pathogenic bacterial agent was 
identified in 41 (43.16%) patients. We isolated the following 
microorganisms: S.pneumoniae – 21 patients, S.aureus – 13, 
Haemophilus influenza – 4 and E.coli – 3 patients. 
It should also be noted that in 2 patients we isolated 
Streptococcus viridans, and in one patient – Staphylococcus 
epidermidis and in another one – Candida spp. However, 
according to the literature, the development of broncho-
pulmonary inflammation for these microorganisms is 
not characteristic. Their isolation from sputum is likely to 
indicate the contamination of the material by the flora of 
the upper respiratory tract, not the etiological significance 
of these microorganisms.
Most patients with pneumonia as a complication of the 
influenza (n = 61; 64.21%) were over 40 years of age. How-
ever, we have noticed a trend that patients who develop 
pneumonia caused by S.aureus, were younger – 23 to 49 
years (mean age 37,46 ± 2,44 years). Whereas in the group 
in which we were not able to isolate the bacterial pathogen 
in sputum, the average age was 49.58 ± 2.22 years (23 to 80 
years), in the group of S.pneumoniae – 57.85 ± 2.89 years 
(28 to 76 years), in the group of Haemophilus influenza 
– 51.50 ± 7.45 years (33 to 69 years) and in the group of 
E.coli – 48.33 ± 7.05 years (35 to 59 years). 
In general, the risk factors for severe influenza and, 
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accordingly, the development of pneumonia were identi-
fied with the following frequency: chronic cardiovascular 
diseases − 42.10% (n = 40), disorders of the respiratory 
system − 36.84% (n = 35), obesity − 7.37% (n = 7), diabetes 
mellitus − 8.42% (n = 8), liver cirrhosis − 2.10% (n = 2), 
long smoking period − 41.05% (n = 39), HIV infection 
– 1.05% (n = 1), neoplasms – 2.10% (n = 2). (Table І). 
Interestingly, the frequency of identifying risk factors for 
severe influenza and concomitant pathology was essentially 
the same when comparing groups with different bacterial 
agents and the group in which we were not able to isolate 
the bacterial pathogen in sputum, except that in the group 
of S.aureus risk factors and concomitant pathology were 
diagnosed significantly less frequently. This was probably 
due to the fact that the patients were in the group S.aureus 
were younger. 
The analysis of the time of admission of patients to the 
hospital showed that early hospitalization prevailed among 
the patients. This fact indirectly indicated a serious course 
of the disease and possible early development of compli-
cations. Almost half of the patients – 42 (44.21%) were 
hospitalized for 1-3 days. The bacterial pathogen was not 
isolated in sputum substantially in all of these patients, 
which may indicate the primary viral nature of possible 
complications. Almost the same number of patients (n 
= 47; 49.47%) were hospitalized for 4-6 days, 6 (6.32%) 
patients were hospitalized after 6 days, with no character-
istic differences between groups of patients with different 
bacterial agents in sputum.
At the pre-admission phase, treatment was prescribed 
to 54 (56.84%) patients: 28 patients received antibacterial 
therapy drugs, 26 received antiviral therapy drugs, which, 
as a rule, were combined with symptomatic agents. 
In most patients, the disease was characterized by an 
acute onset with a predominance of symptoms of general 
toxic syndrome with such frequency: hyperthermia (n = 
94; 98.95%), headache (n = 65; 68.42%), muscle pain (n = 
37; 38.95%). Moreover, 11 (11.59%) patients experienced 
symptoms of severe toxic syndrome, such as nausea and 
vomiting. Catarrhal syndrome of varying severity was 
also observed in the vast majority of patients: scleritis and 
hyperemia of the oropharyngeal mucosa (n = 63; 66.32%), 
dry (n = 61; 64.21%) and productive (n = 30; 31.58) %) 
cough. The dry cough changed on productive in most 
patients in the dynamics (n = 85; 89.47%). The type of 
sputum was mucoid − (n = 60; 63.16%), mucopurulent 
− (n = 26; 27.37%) or bloody − (n = 9; 9.47%). The high 
incidence of chest pain (n = 38; 40.00%) and shortness of 
breath (n = 32; 33.67%) should be noted. Thus, in general, 
the clinical course at the onset of the disease was typical 
substantially in all patients with the prevalence of mani-
festations of toxic syndrome without differences between 
groups of patients with different bacterial agents in sputum, 
except that bloody sputum and severe breathlessness were 
observed only in groups S. pneumoniae (n = 7 and n = 20, 
respectively) or S.aureus (n = 2 and n = 12, respectively) . 
Analysis of physical changes in the lungs in hospitalized 
patients showed that signs of pneumonia (dullness on per-
cussion sound over the affected part of the lung, weakened 
or bronchial breathing, small bubbling rales, crepitations) 
were determined in almost all patients (n=93; 97.89%). 
Of all patients, 10 (10.53%) were assigned to Clinical 
Group IV, among them unilateral inflammatory process 
in lungs was observed only in 1 patient (with S.pneumoni-
ae), in the other 9 patients (4 patients with S.pneumoniae, 
3 patients with S.aureus and 2 patients without isolated 
bacterial agent) the inflammation was bilateral. Clinical 
Group III included 39 (41.05%) patients: 36 patients had 
bilateral and 3 patients had unilateral pneumonia. Clinical 
group II included 46 (48.42%) patients; all except one had 
unilateral lung injury. 
Radiographic picture of pneumonia in patients had 
certain features. Unilateral (n = 49; 51.58%) or bilateral 
inflammatory process (n = 46; 48.42%) was recorded es-
sentially with the same frequency. It should be noted that 
bilateral lesions were mainly observed in patients with 
S.pneumoniae (n = 17), S.aureus (n = 11), or in a group 
of patients without bacterial agent (n = 18) and assumed 
primary viral cause of inflammatory changes in the lungs. 
However, in case of primary viral interstitial inflamma-
tion, we observed a moderate compaction of the lung tissue 
with signs of diffuse bronchiolitis and bronchopneumonia 
(a symptom of “ground-glass”, “tree-and-bud”) with small 
centrilobular foci without decay and rarely with consoli-
dation phenomena. Whereas, as usually with the addition 
of the bacterial flora, the inflammatory process began on 
the periphery and in the lower lobes, first in the form of an 
increased pulmonary vascularity and inhomogeneous nod-
ular opacity, which later spread in severe cases and formed 
massive confluent subtotal or total infiltrative changes in 
the lungs. In some patients, on the background of such 
massive infiltrative changes, microabscesses were formed 
in the lung tissue. Interestingly, in all of these patients with 
abscesses (n = 4), we isoleted S.aureus in sputum. The roots 
of the lungs were substantially expanded and infiltrated. 
By means of an estimation of the x-ray pattern in the 
dynamics, it was found that the resorption of infiltrates 
lasted more than 12 days, and residual pneumonia was 
preserved in the overwhelming majority (n = 84; 88,42%) 
of the persons discharged from the hospital. 
The level of SpO2 was significantly differed depending 
on the prevalence of inflammatory process in the lungs in 
patients. In patients with pneumonia of Clinical Group 
II − III, values of SpO2 ranged from 99% to 91% (mean 
95.1 ± 0.3%) without oxygen inhalation. In the case of 
pneumonia of Clinical Group IV with bilateral lung injury, 
blood oxygen saturation varied from 92 to 60% without 
inhalation of oxygen. Depending on the etiological factor, 
these were the patients with S.pneumoniae (n = 5), S.au-
reus (n = 3), or without any bacterial agent (n = 2) with a 
possible primary viral nature of the disease. All patients 
with pneumonia of Clinical Group IV received treatment 
in the intensive care unit to improve the condition from 4 
to 14 days (mean − 6.3 ± 1.2 days). 
In recent years, the scientific literature has reported a se-
vere course severe course and high mortality of pneumonia, 
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which is caused by a combination of S.aureusand influenza 
virus. This fact is associated with a powerful role of staphy-
lococcus virulence factors in the pathogenesis: Panton-Val-
entine leukocidin, phenol-soluble modulin α1 (PSMα1) 
and -3 (PSMα3), α-hemolysin (Hla), etc. [8, 9, 10, 11]. We 
have identified an association S.aureus and influenza virus 
in 13 (13.68%) patients. The clinical symptomatology of 
pneumonia in these individuals was mainly characterized 
by a severe course, despite the relatively young age of the 
patients. Almost every fourth of these patients (3 out of 13) 
was assigned to Clinical Group IV. Moreover, vast majority 
of patients with S.aureus was characterized by bilateral 
subtotal or total lung injury (11 of 13). 
In the course of our research we aimed to analyze the 
epidemiological data and clinical course of pneumonia as a 
complication of influenza in the Poltava region, depending 
on the etiological factor. We have received original data for 
our region and consider that the results of our research can 
be extrapolated to the whole country, taking into account 
the geographical and socio-economic situation of the 
region. On the other hand, this may be an insignificant 
methodological limitation of the results obtained. However, 
the above data confirm the trends discribed in the literature 
that require further research to optimize the diagnostic 
and therapeutic tactics of pneumonia which complicate 
influenza, depending on their etiological agent.
CONCLUSIONS 
Studies have shown that despite a decrease in the incidence 
of influenza in recent years, the incidence of pneumonia, 
which complicated the course of influenza, remained 
consistently high (19.7% – 20.8%) with bacteriological 
isolation of S.pneumoniae (22.11%), S.aureus (13.68%), 
Haemophilus influenza (4.21%) and E.coli (3.16%). Severe 
course of pneumonia with bloody sputum, evident short-
ness of breath, bilateral lung damage, and need for oxygen 
support were significantly more frequently reported in 
patients with isolated S.pneumoniae and S.aureus. How-
ever, the severe course of the disease with the formation 
of abscesses in the lungs was observed only in the group 
S.aureus despite the relatively young age of such patients 
and significantly fewer risk factors for severe influenza 
and comorbidities.
Table I. Demographic indicators and the frequency of the risk factors of the complicated course of influenza in the examined patients with pneumonia





abs. % abs. % abs. % abs. % abs. % abs. % abs. %
Gender
male 52 54.74 27 54.00 12 57.14 8 61.54 2 50.00 2 66.67 2 50.00
female 43 45.26 23 46.00 9 42.86 5 38.46 2 50.00 1 33.33 2 50.00
Age
18-30 16 16.84 12 24.00 2 9.52 2 15.38 - - - -
31–40 18 18.95 4 8.00 3 14.29 8 61.54 1 25.00 1 33.33 1 25.00
41–50 19 20.00 7 14.00 5 23,81 3 23.08 1 25.00 1 33.33 2 50.00
51–60 27 28.42 20 40.00 4 19.05 - - 1 25.00 1 33.33 1 25.00











40 42.11 23 46.00 13 61.90 2 15.38* 1 25.00 1 33.33 - -
оbesity 7 7.37 5 10.00 2 9.52 - - - - - -
diabetes 
mellitus 8 8.42 5 10.00 2 9.52 - - - - 1 25.00
hepatic 
cirrhosis 2 2.11 1 2.00 1 4.76 - - - -
smoking 39 41.05 16 32.00 11 52.38 7 53.85 2 50.00 1 33.33 2 50.00
HIV infection 1 1.05 1 2.00 - - - - - - - -
malignant 
neoplasms 2 2.11 1 2.00 1 4.76 - - - - - -
Note. Percentages were calculated from the number of patients in the appropriate group, depending on the etiologic agent
* - significant difference compared to the patients in the group S.pneumoniae and group without bacterial agent (p < 0.05)
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